Predicting Progression Free Survival after Systemic Therapy in Advanced Head and Neck Cancer: Bayesian regression and Model development
View ORCID ProfilePaul R Barber, View ORCID ProfileFabian Flores-Borja, Giovanna Alfano, Kenrick Ng, Gregory Weitsman, Luigi Dolcetti, Rami Mustapha, Felix Wong, Jose M Vicencio, Myria Galazi, View ORCID ProfileJames W Opzoomer, James N Arnold, View ORCID ProfileShahram Kordasti, Jana Doyle, Jon Greenberg, Magnus T Dillon, Kevin J Harrington, Martin D Forster, Anthony C C Coolen, View ORCID ProfileTony Ng
doi: https://doi.org/10.1101/2021.09.22.21263942
Paul R Barber
1UCL Cancer Institute, Paul O’Gorman Building, University College London, London, UK
2Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Fabian Flores-Borja
3Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Giovanna Alfano
4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Kenrick Ng
1UCL Cancer Institute, Paul O’Gorman Building, University College London, London, UK
Gregory Weitsman
4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Luigi Dolcetti
4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Rami Mustapha
4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Felix Wong
4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Jose M Vicencio
1UCL Cancer Institute, Paul O’Gorman Building, University College London, London, UK
4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Myria Galazi
1UCL Cancer Institute, Paul O’Gorman Building, University College London, London, UK
James W Opzoomer
5Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
James N Arnold
5Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Shahram Kordasti
6Systems Cancer Immunology, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Jana Doyle
7Daichii Sankyo Incorporated, New Jersey, USA
Jon Greenberg
7Daichii Sankyo Incorporated, New Jersey, USA
Magnus T Dillon
8The Institute of Cancer Research, London, UK
Kevin J Harrington
8The Institute of Cancer Research, London, UK
Martin D Forster
1UCL Cancer Institute, Paul O’Gorman Building, University College London, London, UK
Anthony C C Coolen
9Institute for Mathematical and Molecular Biomedicine, King’s College London, UK
10Saddle Point Science Ltd, London, UK
Tony Ng
1UCL Cancer Institute, Paul O’Gorman Building, University College London, London, UK
3Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
Article usage
Posted September 23, 2021.
Predicting Progression Free Survival after Systemic Therapy in Advanced Head and Neck Cancer: Bayesian regression and Model development
Paul R Barber, Fabian Flores-Borja, Giovanna Alfano, Kenrick Ng, Gregory Weitsman, Luigi Dolcetti, Rami Mustapha, Felix Wong, Jose M Vicencio, Myria Galazi, James W Opzoomer, James N Arnold, Shahram Kordasti, Jana Doyle, Jon Greenberg, Magnus T Dillon, Kevin J Harrington, Martin D Forster, Anthony C C Coolen, Tony Ng
medRxiv 2021.09.22.21263942; doi: https://doi.org/10.1101/2021.09.22.21263942
Predicting Progression Free Survival after Systemic Therapy in Advanced Head and Neck Cancer: Bayesian regression and Model development
Paul R Barber, Fabian Flores-Borja, Giovanna Alfano, Kenrick Ng, Gregory Weitsman, Luigi Dolcetti, Rami Mustapha, Felix Wong, Jose M Vicencio, Myria Galazi, James W Opzoomer, James N Arnold, Shahram Kordasti, Jana Doyle, Jon Greenberg, Magnus T Dillon, Kevin J Harrington, Martin D Forster, Anthony C C Coolen, Tony Ng
medRxiv 2021.09.22.21263942; doi: https://doi.org/10.1101/2021.09.22.21263942
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)